| scholarly article | Q13442814 |
| P2093 | author name string | Junker R | |
| Kosch A | |||
| Kurnik K | |||
| Luigs P | |||
| Nabel P | |||
| Nowak-Göttl U | |||
| Schobess R | |||
| Sträter R | |||
| Vielhaber H | |||
| von Eckardstein A | |||
| P2860 | cites work | A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase | Q24324172 |
| Stroke in childhood. | Q33662944 | ||
| Mutation in blood coagulation factor V associated with resistance to activated protein C. | Q34340007 | ||
| Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction | Q34545496 | ||
| Cerebrovascular disease in infants and children: A study of incidence, clinical features, and survival | Q40064201 | ||
| Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. | Q40907195 | ||
| Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
| Stroke in children. Clinical characteristics and prognosis | Q44613570 | ||
| Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study | Q44661558 | ||
| Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. | Q48169343 | ||
| Genetic analysis of the thermolabile variant of 5, 10-methylenetetrahydrofolate reductase as a risk factor for ischemic stroke | Q48285132 | ||
| Methylenetetrahydrofolate reductase gene polymorphism and ischemic stroke in Japanese | Q48393197 | ||
| Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome | Q48958937 | ||
| Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds | Q49227514 | ||
| Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. | Q50911423 | ||
| Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. | Q50977258 | ||
| Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. | Q54082147 | ||
| Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. | Q54121107 | ||
| Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. | Q54185666 | ||
| Activated protein C resistance in childhood stroke | Q58320642 | ||
| The 4G/4G genotype at nucleotide position -675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls | Q58959984 | ||
| The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease | Q63439579 | ||
| Plasminogen Activator Inhibitor-1 (PAI-1) Antigen Plasma Levels in Subjects Attending a Metabolic Ward: Relation to Polymorphisms of PAI-1 and Angiontensin Converting Enzyme (ACE) Genes | Q63439593 | ||
| Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity | Q68290719 | ||
| Computed tomographic patterns of proven embolic brain infarctions | Q69414422 | ||
| Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke | Q70024231 | ||
| Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke | Q72773126 | ||
| Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke | Q73334504 | ||
| Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) | Q74324113 | ||
| Thrombophilic disorders in children with cerebral infarction | Q77664583 | ||
| Plasminogen activator inhibitor-1 4G/5G-polymorphism and factor V Q506 mutation are not associated with myocardial infarction in young men | Q77719029 | ||
| Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study | Q77765078 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 57-62 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | European Journal of Haematology | Q15765799 |
| P1476 | title | The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group | |
| P478 | volume | 66 |
| Q38172629 | Advances in understanding stroke risk in children--a geneticist's view |
| Q38383836 | Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility |
| Q51096258 | Association of Polymorphisms in Coagulation Factor Genes and Enzymes of Homocysteine Metabolism With Arterial Ischemic Stroke in Children. |
| Q37141815 | Genetic polymorphisms for the study of multifactorial stroke. |
| Q37274431 | Hematological diseases and stroke |
| Q27687460 | Inherited prothrombotic risk factors in children with first ischemic stroke |
| Q90145895 | Lack of Associations Between PAI-1 and FXIII Polymorphisms and Arterial Ischemic Stroke in Children: A Systematic Review and Meta-Analysis |
| Q83528804 | Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke |
| Q54313400 | Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults. |
| Q36963100 | The black box of perinatal ischemic stroke pathogenesis |
| Q35283067 | Thrombophilia and first arterial ischaemic stroke: a systematic review |
| Q48901051 | Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion |
Search more.